BREAST CANCER INVASIVE

This study is for people with HER2-positive breast cancer who have already had initial treatment. It compares taking the drug pyrotinib every day versus taking it on a schedule with breaks. The goal is to see if intermittent dosing works as well as continuous dosing to prevent th…

This study is for people with stage 2 or 3 breast cancer. It tests whether giving a special type of radiation (SBRT) and an immunotherapy drug (pembrolizumab) directly into the tumor before standard chemotherapy can help shrink the cancer more effectively. The goal is to see if t…

This study is gathering images from 800 women who have suspicious breast findings (BI-RADS 4 or 5) to test a new 3D automated ultrasound system called ATUSA. The goal is to see if this radiation-free, operator-independent device can accurately detect breast cancer compared to sta…

This study tests whether drinking tart cherry juice can help prevent nerve damage (neuropathy) caused by the chemotherapy drug paclitaxel in people with breast or ovarian cancer. About 86 participants will be randomly assigned to take either a high or low dose of the juice daily …

This study looks at how the immune system responds in people with early-stage triple negative breast cancer who are receiving standard chemotherapy combined with immunotherapy (pembrolizumab). Researchers will measure certain immune markers in blood and tissue samples to see if t…

This study is for people with high-risk early-stage breast cancer. It tests whether taking a low dose of the drug azacitidine before surgery can increase immune cells (called TILs) inside the tumor. The goal is to see if the drug can make the immune system more active against the…

This study is testing a new blood test (called a liquid biopsy) to track breast cancer over time. About 93 women with early or advanced breast cancer will give blood samples at several visits. The goal is to see if counting cancer cells in the blood can give doctors useful inform…

This study tests a special scanner that helps surgeons see if all cancer has been removed during breast-conserving surgery. About 100 women with invasive breast cancer will take part. The goal is to see if using the scanner reduces the need for a second surgery.

This study is testing whether short educational videos can help Spanish-speaking Latinx patients with breast or prostate cancer better understand radiation therapy and feel more comfortable about joining clinical trials. About 194 participants will watch a video or read a brochur…